Temozolomide CAS 85622-93-1
Identification
Properties
Safety Data
Specifications & Other Information
Links
Identification
CAS Number
85622-93-1
Name
Temozolomide
Synonyms
3-Methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazin-8-carboxamid [German] [ACD/IUPAC Name]
3-Methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide [ACD/IUPAC Name]
3-Méthyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tétrazine-8-carboxamide [French] [ACD/IUPAC Name]
85622-93-1 [RN]
Imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide, 3,4-dihydro-3-methyl-4-oxo- [ACD/Index Name]
M&B 39831
Temodal [Trade name]
TEMODAR [Trade name]
Temozolamide
Temozolodida [Spanish] [INN]
Temozolomide [BAN] [INN] [JAN] [USAN] [Wiki]
Temozolomidum [Latin] [INN]
UNII:YF1K15M17Y
[147127-20-6]
208107-14-6 [RN]
3,4-Dihydro-3-methyl-4-oxoimidazo(5,1-d)-1,2,3,5-tetrazine-8-carboxamide
3,4-Dihydro-3-methyl-4-oxoimidazo(5,1-d)-as-tetrazine-8-carboxamide
3,4-Dihydro-3-methyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide
3,4-dihydro-3-methyl-4-oxo-imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide
3,4-Dihydro-3-methyl-4-oxoimidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide
3-Methyl-4-oxo-3,4-dihydroimidazo(5,1-d)(1,2,3,5)tetrazine-8-carboxamide
3-Methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetraazine-8-carboxamide
3-Methyl-4-oxo-3,4-dihydroimidazo-[5,1-d][1,2,3,5]tetrazine-8-carboxamide
3-Methyl-4-oxo-3,4-dihydro-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxylic acid amide
3-methyl-4-oxo-3H,4H-imidazo[4,3-d][1,2,3,5]tetrazine-8-carboxamide
3-methyl-4-oxo-8-imidazo[5,1-d][1,2,3,5]tetrazinecarboxamide
3-Methyl-4-oxo-8-imidazolo[5,1-d][1,2,3,5]tetrazinecarboxamide
3-methyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide
3-methyl-4-oxo-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide
3-methyl-4-oxoimidazo[5,1-d]1,2,3,5-tetraazine-8-carboxamide
4-keto-3-methyl-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide
4-Methyl-5-oxo-2,3,4,6,8-pentazabicyclo[4.3.0]nona-2,7,9-triene-9-carboxamide
8-carbamoyl-3-methylimidazo(5,1-d)-1,2,3,5-tetrazin-4(3H)-one
8-Carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one
BR-72945
C047246
CCRG-81045|M-39831|Temodal®|Temodar®
CCRIS 8996
D06067
Imidazo(5,1-d)(1,2,3,5)tetrazine-8-carboxamide, 3,4-dihydro-3-methyl-4-oxo-
Imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide, 3, 4-dihydro-3-methyl-4-oxo-
M & B 39831
M&B-39831
M-39831
Methazolastone
Methazolastone, Temodar, Temodal
MFCD00866492 [MDL number]
MFCD07357269
MLS000759447
NJ5927050
NSC 362856 | CCRG 81045 |
NSC 362856; CCRG 81045; TZM
OR-2567
Pharmakon1600-01502289
SMR000466338
Temodal (TN)
Temodal®
Temodal; Temodar
Temodar®
Temozolimide
Temozolodida
Temozolodida; Temozolomid; Témozolomide; Temozolomidum
Temozolomid
temozolomida
temozolomida; temozolomide; temozolomidum
Témozolomide
Temozolomidum
Temozolomidum [Latin]
TL8005593
TMZ
TMZ; NSC 362856; SCH 52365; CCRG 81045
TZM
UNII-YF1K15M17Y
YF1K15M17Y
Molecular Structure
SMILES
Cn1c(=O)n2cnc(c2nn1)C(=O)N
StdInChI
InChI=1S/C6H6N6O2/c1-11-6(14)12-2-8-3(4(7)13)5(12)9-10-11/h2H,1H3,(H2,7,13)
StdInChIKey
BPEGJWRSRHCHSN-UHFFFAOYSA-N
Molecular Formula
C6H6N6O2
Molecular Weight
194.15
MDL Number
MFCD00866492
Properties
Appearance
White to almost reddish powder
Safety Data
Symbol
GHS07, GHS08Signal Word
Danger
Hazard Statements
Precautionary Statements
P201-P261-P305 + P351 + P338-P308 + P313
Personal Protective Equipment
Eyeshields, full-face particle respirator type N100 (US), Gloves, respirator cartridge type N100 (US), type P1 (EN143) respirator filter, type P3 (EN 143) respirator cartridges
RIDADR
NONH for all modes of transport
WGK Germany
3
RTECS
NJ5927050
Specifications and Other Information of Our Temozolomide CAS 85622-93-1
Standard
CP2015
Identification Methods
HPLC,IR
Assay
98%~102%
Heavy Metals
10ppm max
Loss on Drying
0.5%max
Residual solvent
DMSO: ≤5000ppm
Residue on Ignition
0.1%max
Known Impurity
0.5%max
Unknown Impurities
0.5%max
Total Impurities
1.0%max
Package
According to customer requirements to packaging
Storage
Under the room temperature and away from light
Application
Commonly used as anti-cancer drugs. In the body can spontaneously and rapidly degrade the active metabolite MTIC, resulting in anti-tumor effect.
Links
Caming Pharmaceutical Ltd
This product is developed by our sub R&D company Caming Pharmaceutical Ltd, and please click the link below for details.
http://www.caming.com/temozolomide-cas-85622-93-1/
Watson International Ltd
This product is sold exclusively through our sales company Watson International Ltd, and please click the link below for details.
http://www.watson-int.com/temozolomide-cas-85622-93-1/